Essilor Overview

  • Founded
  • 1848

Founded

  • Status
  • Public

  • Employees
  • 191,144

Employees

  • Stock Symbol
  • EL

Stock Symbol

  • Investments
  • 210

  • Share Price
  • $179.06
  • (As of Friday Closing)

Essilor General Information

Description

EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 46% in North America, and the rest in Asia and Latin America.

Contact Information

Website
www.essilor.com
Formerly Known As
Compagnie Generale D'Optique
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Stock Exchange
PAR
Primary Office
  • 147 rue de Paris
  • 94220 Charenton-le-Pont
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Essilor Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$179.06 $180.45 $132.42 - $206.50 450M 400K $5.50

Essilor Financials Summary

In Thousands,
USD 		TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 96,351,802 91,960,623 96,770,697 74,193,119
Revenue 26,526,384 25,753,067 23,433,159 16,447,803
EBITDA 6,493,738 6,395,685 5,531,975 2,948,955
Net Income 2,447,446 2,262,619 1,711,968 96,893
Total Assets 65,449,151 64,945,469 67,270,895 64,349,409
Total Debt 12,765,981 13,087,540 14,738,117 14,630,456
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Essilor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Essilor‘s full profile, request access.

Request a free trial

Essilor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufactu
Therapeutic Devices
Charenton-le-Pont, France
191,144 As of 2023
000000000

000000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
0000000000 000000000
Irvine, CA
0000 As of 0000
00000
000000000 00000

0000 0

met, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000000000 000000000
Jena, Germany
0000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Essilor Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Masimo Formerly VC-backed Irvine, CA 0000 00000 000000000 00000
0000 00000 0000000 Corporation Jena, Germany 0000 00000 00000000 00000
0000 00000 Corporation Tokyo, Japan 00000 00000000
You’re viewing 3 of 3 competitors. Get the full list »

Essilor Patents

  • 251

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 102

    Pending

  • 000

    Expiring in next 12 mo

Essilor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4242736-A1 System comprising an optical device and a controller Pending 11-Mar-2022 000000000 0
EP-4227910-A1 Computer implemented method for determining a similarity score between a reference eyeglasses frame and a plurality of model eyeglasses frames Pending 14-Feb-2022 000000000 0
EP-4219787-A1 Physical vapor deposition machine with a thermal evaporator having a cup heated-up by electric current Pending 28-Jan-2022 0000000000 0
EP-4218540-A1 Method for simulating an ophthalmic lens on an eye of a subject viewing a virtual three-dimensions scene using a light field display Pending 26-Jan-2022 0000000000 0
EP-4209168-A1 Application for myopia monitoring Pending 07-Jan-2022 A61B3/032 0
To view Essilor’s complete patent history, request access »

Essilor Executive Team (40)

Name Title Board Seat Contact Info
Francesco Milleri Chief Executive Officer & Chairman
Paul du Saillant Board Member & Deputy CEO
Fabrizio Uguzzoni President of North America Wholesale, EssilorLuxottica
Norbert Gorny Co-Chief Operating Officer & Board Member
Jeremy Teo Global Chief Strategy Officer
You’re viewing 5 of 40 executive team members. Get the full list »

Essilor Board Members (24)

Name Representing Role Since
0000000 00000 Self Board Member 000 0000
000000000 0000000 Essilor Chief Executive Officer & Chairman 000 0000
0000-000 00000000 Self Board Member 000 0000
00000000 0000000 Self Chairman & Board Member 000 0000
00000000 0000000 0 Self Board Member 000 0000
You’re viewing 5 of 24 board members. Get the full list »

Essilor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Essilor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Essilor‘s full profile, request access.

Request a free trial

Essilor Investments & Acquisitions (210)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 25-Jul-2023 0000000000 Electronics (B2C) 000000000
00 (000000000 10-May-2023 00000 0000 Accessories 000000000
00000000 06-Feb-2023 000000000 Buildings and Property
000000 000000 03-Aug-2022 000000000 00000 Therapeutic Devices 000000000
Walman Optical 28-Feb-2022 Merger/Acquisition Therapeutic Devices 0000 00 0
You’re viewing 5 of 210 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Essilor Subsidiaries (95)

Company Name Industry Location Founded
SightGlass Vision Therapeutic Devices Palo Alto, CA 2016
000000 0000000 Electronics (B2C) Tel Aviv, Israel 0000
00000 000000 Accessories Prahova, Romania 0000
0000000 00000 0000 Other Consumer Non-Durables Danyang, China 0000
0Ó0000 Specialty Retail Sao Paulo, Brazil 0000
You’re viewing 5 of 95 subsidiaries. Get the full list »

Essilor ESG

Risk Overview

Risk Rating

Updated August, 09, 2023

20.37 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,491

Rank

00.00

Percentile

Healthcare

Industry

00 of 607

Rank

00.00

Percentile

Medical Supplies

Subindustry

00 of 57

Rank

00.00

Percentile

To view Essilor’s complete esg history, request access »

Essilor Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000 01-Jul-2015 000000000000000000 Completed
  • 0000000
0000 12-May-2009 00000 00000 00 00.000 Completed
  • 6 buyers
0000 23-Sep-2008 00000 00000 00 000 Completed
  • 6 buyers
0000 25-Jun-2007 00000 00000 00 00.000 Completed
  • 6 buyers
Polylite Taiwan Company 01-Jan-2006 Merger/Acquisition Completed
To view Essilor’s complete exits history, request access »